Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effects of a Traditional Caraway Formulation on Experimental Models of Vitiligo and Mechanisms of Melanogenesis. | Evid Based Complement Alternat Med | 2021 | 33959187 | PubTator, text mining | PubMed |
| Antioxidant and Antimelanogenic Activities of Kimchi-Derived Limosilactobacillus fermentum JNU532 in B16F10 Melanoma Cells. | J Microbiol Biotechnol | 2021 | 33958510 | PubTator, text mining | PubMed |
| Structural characterization of a Type B chloramphenicol acetyltransferase from the emerging pathogen Elizabethkingia anophelis NUHP1. | Sci Rep | 2021 | 33947893 | PubTator, text mining | PubMed |
| Identification of a novel heterozygous mutation in the MITF gene in an Iranian family with Waardenburg syndrome type II using next-generation sequencing. | J Clin Lab Anal | 2021 | 33942382 | PubTator, text mining | PubMed |
| UTMOST, a single and cross-tissue TWAS (Transcriptome Wide Association Study), reveals new ASD (Autism Spectrum Disorder) associated genes. | Transl Psychiatry | 2021 | 33931583 | PubTator, text mining | PubMed |
| Prognostic and Predictive Biomarkers in Stage III Melanoma: Current Insights and Clinical Implications. | Int J Mol Sci | 2021 | 33925387 | PubTator, text mining | PubMed |
| Marliolide Derivative Induces Melanosome Degradation via Nrf2/p62-Mediated Autophagy. | Int J Mol Sci | 2021 | 33924406 | PubTator, text mining | PubMed |
| Novel Quercetin Derivative of 3,7-Dioleylquercetin Shows Less Toxicity and Highly Potent Tyrosinase Inhibition Activity. | Int J Mol Sci | 2021 | 33923988 | PubTator, text mining | PubMed |
| New Sequence Type ST3449 in Multidrug-Resistant Pseudomonas aeruginosa Isolates from a Cystic Fibrosis Patient. | Antibiotics (Basel) | 2021 | 33922748 | PubTator, text mining | PubMed |
| How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma. | Cancers (Basel) | 2021 | 33922591 | PubTator, text mining | PubMed |
| From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis. | Cancers (Basel) | 2021 | 33922182 | PubTator, text mining | PubMed |
| Diversified Stimuli-Induced Inflammatory Pathways Cause Skin Pigmentation. | Int J Mol Sci | 2021 | 33921371 | PubTator, text mining | PubMed |
| A Highlight on the Inhibition of Fungal Carbonic Anhydrases as Drug Targets for the Antifungal Armamentarium. | Int J Mol Sci | 2021 | 33919261 | PubTator, text mining | PubMed |
| Development of Pigmentation-Regulating Agents by Drug Repositioning. | Int J Mol Sci | 2021 | 33918792 | PubTator, text mining | PubMed |
| Oenothera laciniata Hill Extracts Exhibits Antioxidant Effects and Attenuates Melanogenesis in B16-F10 Cells via Downregulating CREB/MITF/Tyrosinase and Upregulating p-ERK and p-JNK. | Plants (Basel) | 2021 | 33917957 | PubTator, text mining | PubMed |
| Protocatechuic Aldehyde Inhibits α-MSH-Induced Melanogenesis in B16F10 Melanoma Cells via PKA/CREB-Associated MITF Downregulation. | Int J Mol Sci | 2021 | 33917915 | PubTator, text mining | PubMed |
| ATP7A-Regulated Enzyme Metalation and Trafficking in the Menkes Disease Puzzle. | Biomedicines | 2021 | 33917579 | PubTator, text mining | PubMed |
| A prepared platelet-rich plasma extract, namely Self-Growth Colony, inhibits melanogenesis by down-regulating microphthalmia-associated transcription factor in skin melanocyte. | J Cosmet Dermatol | 2021 | 33896085 | PubTator, text mining | PubMed |
| Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis. | Hereditas | 2021 | 33892811 | PubTator, text mining | PubMed |
| A BLOC-1-AP-3 super-complex sorts a cis-SNARE complex into endosome-derived tubular transport carriers. | J Cell Biol | 2021 | 33886957 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=49